Vero Biotech
About:
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Website: https://www.vero-biotech.com
Twitter/X: verobiotech
Top Investors: Runway Growth Capital, MVM Life Science Partners, Petrichor Healthcare Capital Management
Description:
Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients with a variety of pulmonary and cardiac diseases. They are currently developing inhaled nitric oxide (NO) products for use in both the hospital setting and for longer-term applications outside of the hospital setting. These products, which are based on our GeNOsylâ„¢ drug delivery technology, are comprised of a single-use drug cassette and either a portable console or wearable controller. Its technology is designed to deliver NO safely for a variety of therapeutic indications and to provide clinicians with a solution that is more user-friendly than currently available NO delivery systems.
$235M
$10M to $50M
Atlanta, Georgia, United States
2006-01-01
contactus(AT)genollc.com
101-250
2023-01-11
Private
© 2025 bioDAO.ai